Home/About
About Lotus Nutra

We’re a lab.Not a manufacturer.

Most formulation firms blur the line between R&D services and manufacturing. They take title to your inventory, process your funds, or sign your co-man contracts on your behalf. That blur creates exposure on both sides — for them and for you.

Lotus Nutra is built differently. Under Path A architecture, the line is sharp on purpose: we deliver the IP, you select your co-man, your contract is with them.

Path A architectureTampa, FL
Path A Architecture

What we do.
And what we deliberately don’t.

Four operational commitments. They are the architecture — not aspirational language — and they sit inside every MFSA we sign.
01 · Deliverable

We deliver the formulation. Full stop.

Our scope ends at a manufacturer-ready formulation package. The three iterations and the Acceptance Certificate define exactly what you receive and when our obligations conclude.

02 · Disclosure

We surface co-manufacturer options — as disclosure, not as agency.

We introduce vetted co-mans from our network and forward their certificates of insurance as courtesy disclosure. You decide who you contract with; we never broker the relationship.

03 · Contract

You contract with the co-manufacturer directly.

Their COI covers their work; your product liability covers yours. The insurance lineage is legible and the manufacturer-of-record sits where it belongs — with the manufacturer.

04 · What we never do

No inventory. No customer funds. No contracts in our name.

We never take title to inventory, process customer funds, or sign co-man contracts on your behalf. The line that separates R&D from manufacturing stays sharp.

For your diligence team

Why this matters
for your investors.

Funded brands need a clean liability story. Path A delivers one: the formulation IP is bought-and-paid-for; the manufacturer is on your contract; your insurance lineage is clear; your Acceptance Certificate marks the exact boundary of our involvement.

That’s the story your diligence team wants to read — not a vague “formulation partner” relationship that could be re-characterized at audit.

  • Bought-and-paid-for IP.Tier 1, 2, or 3 — the assignment terms are written into Exhibit F.
  • Manufacturer-of-record on your contract. The co-man’s COI sits with their work; yours sits with yours.
  • Clear insurance lineage. No co-mingled coverage, no shared exposure perimeter.
  • Bounded scope. The Acceptance Certificate is the exact line where our performance obligations end.
The team

Built by operators,
for operators.

Lotus Nutra is headquartered in Tampa, Florida. We formulate beverage and gummy products for brands in the functional, adaptogenic, kava, kratom, and cannabinoid spaces.

Headquarters
Tampa, FL
Engagement model
Path A · MFSA
Compensation
Never % of sales
Contract framework
MFSA
What we’re good at

Formulation depth across regulated and adjacent categories.

  • BEVERAGEAcidified beverage development with Process Authority coordination
  • GUMMYGummy and chewable formulations across pectin and gelatin systems
  • DELIVERYNano- and micro-encapsulation for cannabinoid and botanical actives
  • CANNABINOIDCBD / CBG / CBN / THC formulation under federal frameworks
  • KAVA / KRATOMFormulation with monograph-aware label design
Ready when you are

Bring us a brief.

We’ll respond within two business days with scope, timeline, and a draft tier recommendation.

MFSA · three iterations · one Acceptance Certificate